224 related articles for article (PubMed ID: 33327658)
1. Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.
Aliotta A; Krüsi M; Bertaggia Calderara D; Zermatten MG; Gomez FJ; Batista Mesquita Sauvage AP; Alberio L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327658
[TBL] [Abstract][Full Text] [Related]
2. Sodium-Calcium Exchanger Reverse Mode Sustains Dichotomous Ion Fluxes Required for Procoagulant COAT Platelet Formation.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Mar; 121(3):309-321. PubMed ID: 33099282
[TBL] [Abstract][Full Text] [Related]
3. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
Alberio L; Ravanat C; Hechler B; Mangin PH; Lanza F; Gachet C
Thromb Haemost; 2017 Jun; 117(6):1101-1114. PubMed ID: 28382366
[TBL] [Abstract][Full Text] [Related]
4. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity--a comparison with Scott syndrome.
Weiss HJ; Lages B
Blood; 1997 Mar; 89(5):1599-611. PubMed ID: 9057642
[TBL] [Abstract][Full Text] [Related]
5. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
[TBL] [Abstract][Full Text] [Related]
6. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
[TBL] [Abstract][Full Text] [Related]
7. Disorders of platelet function.
Bennett JS; Kolodziej MA
Dis Mon; 1992 Aug; 38(8):577-631. PubMed ID: 1321709
[TBL] [Abstract][Full Text] [Related]
8. Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
Daskalakis M; Colucci G; Keller P; Rochat S; Silzle T; Biasiutti FD; Barizzi G; Alberio L
Cytometry B Clin Cytom; 2014 Nov; 86(6):397-409. PubMed ID: 24677789
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Oct; 121(10):1337-1344. PubMed ID: 33690868
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Lisman T; Moschatsis S; Adelmeijer J; Nieuwenhuis HK; De Groot PG
Blood; 2003 Mar; 101(5):1864-70. PubMed ID: 12411291
[TBL] [Abstract][Full Text] [Related]
11. Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.
Lages B; Weiss HJ
Br J Haematol; 2001 Apr; 113(1):65-71. PubMed ID: 11328283
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect.
Gemmell CH; Sefton MV; Yeo EL
J Biol Chem; 1993 Jul; 268(20):14586-9. PubMed ID: 8325838
[TBL] [Abstract][Full Text] [Related]
15. Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia.
Blair TA; Michelson AD; Frelinger AL
Sci Rep; 2018 Jul; 8(1):10300. PubMed ID: 29985398
[TBL] [Abstract][Full Text] [Related]
16. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ
Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325
[TBL] [Abstract][Full Text] [Related]
17. New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC; Di Minno G; d'Oiron R; Zotz R
Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
[TBL] [Abstract][Full Text] [Related]
18. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
Cox AD; Devine DV
Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
[TBL] [Abstract][Full Text] [Related]
19. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
[TBL] [Abstract][Full Text] [Related]
20. Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
Hu L; Du L; Zhao Y; Li W; Ouyang Q; Zhou D; Lu G; Lin G
Stem Cell Res; 2017 Apr; 20():14-20. PubMed ID: 28232155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
